Incorporating continuing education into single-drug REMS: Exploring the challenges and opportunities Gregory W. Daniel and Mark B. McClellan Wednesday, May 20, 2015
Faster, more efficient innovation through better evidence on real-world safety and effectiveness Mark B. McClellan, Gregory W. Daniel, Adam Aten, Heather M. Colvin, and Morgan H. Romine Tuesday, April 28, 2015
Strengthening patient care: Building an effective national medical device surveillance system Heather Colvin, Pranav Aurora, Saha Khaterzai, Gregory W. Daniel, and Mark B. McClellan Monday, February 23, 2015
I Improving evidence developed from population-level experience with targeted agents Gregory W. Daniel and Mark B. McClellan Monday, February 9, 2015
I Improving Pharmaceutical Innovation by Building a More Comprehensive Database Gregory W. Daniel and Mark B. McClellan Monday, February 2, 2015
R Repairing the Broken Market for Antibiotics Innovation Gregory W. Daniel, Mark B. McClellan, Kevin Outterson, and John H. Powers Monday, February 2, 2015
Unique Device Identifiers (UDIs): A Roadmap for Effective Implementation Mark B. McClellan, Siromi Gardina, Gregory W. Daniel, Dalia Deak, Jonathan Bryan, and Craig Streit Friday, December 5, 2014
C Coverage With Evidence Development for Medicare Beneficiaries Gregory W. Daniel, Erin K. Rubens, and Mark B. McClellan Wednesday, May 1, 2013